[1] 胡芸芸, 王江波.降钙素原指导ICU危重患者抗菌治疗的临床价值[J]. 中外女性健康研究, 2016(16):160, 162. [2] 任乐宁, 夏征. ICU脓毒血症者凝血功能及炎症因子相关性分析[J]. 现代医用影像学, 2018, 27(5):1815-1816. [3] 丁政,顾小宇.ICU感染患者凝血障碍与脓毒症严重程度的关系探讨[J].中外医疗,2019,38(1):49-50,167. [4] SAR R, KARAKURT Z, AY M, et al. Neutrophil to lymphocyte ratio as a predictor of treatment response and mortality in septic shock patients in the intensive care unit[J]. Turk J Med Sci, 2019, 49(5):1336-1349. [5] YANG B, WANG J Q, TAO X G, et al. Clinical investigation on the risk factors for prognosis in patients with septic shock[J]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2019, 31(9):1078-1082. [6] WARKENTIN T E, AIRD W C, RAND J H. Platelet-endothelial interactions:sepsis, HIT, and antiphospholipid syndrome[J]. Hematol Am Soc Hematol Educ Program, 2003, 2003:497-519. [7] GUO X Q, LIU Y H, LI D, et al. Plasma thrombomodulin levels are associated with endothelial injury in patients with bacterial infections[J]. Clin Lab, 2019. DOI:10.7754/Clin.Lab.2019.190134. [8] 刘乐乐,李华.中性粒细胞和淋巴细胞VCS参数与NLR对肿瘤患者化疗后细菌感染辅助诊断价值[J].中华肿瘤防治杂志,2019,26(3):190-193. [9] 李宁, 孙文伟, 赵建军, 等. 血清降钙素原在社区获得性肺炎诊治中的临床应用价值[J]. 吉林大学学报(医学版), 2015, 41(2):352-355. [10] WANG H D. Predictive value of serum procalcitonin and hypersensitive C-reactive protein levels in patients with acute cerebral infarction complicated with infection[J]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2019, 31(8):962-966. [11] BOZKAYA D, YIGIT Ş, YURDAKOK M. Is serum procalcitonin level a reliable indicator in early diagnosis of congenital pneumonia?[J]. Turk J Pediatr, 2019, 61(1):34-39. [12] ASSINK-DE JONG E, DE LANGE D W, VAN OERS J A,et al. Stop Antibiotics on guidance of Procalcitonin Study (SAPS):a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients:calculated sample size:1816 patients[J]. BMC Infect Dis, 2013, 13:178. [13] SPOTO S, FOGOLARI M, DE FLORIO L, et al. Procalcitonin and MR-proAdrenomedullin combination in the etiological diagnosis and prognosis of sepsis and septic shock[J]. Microb Pathog, 2019, 137:103763. [14] JEKARL D W, LEE S, KIM M, et al. Procalcitonin as a prognostic marker for sepsis based on SEPSIS-3[J]. J Clin Lab Anal, 2019, 33(9):e22996. [15] 刘阳桦, 吴敏. 细菌性血流感染所致脓毒症患者凝血-炎症生物标志物水平变化的临床意义[J]. 中国病原生物学杂志, 2017, 12(3):270-273. [16] 洪峰,周大勇.降钙素原、血小板及D-二聚体检测在脓毒症预后中的价值[J].蚌埠医学院学报,2018,43(11):1471-1473. [17] 门学千,李贺明,董茜,等.肿瘤内科住院患者静脉血栓危险因素分析及现有风险评估模型预测价值研究[J].中国实用内科杂志,2019,39(8):694-697. [18] 曲远青, 刘涛, 刘媛, 等. 不同病程的细菌性炎症患者中降钙素原与凝血功能指标的相关性分析[J]. 免疫学杂志, 2015, 31(5):417-420. [19] 陈崇,周桃玉,温旺荣.中性粒细胞/淋巴细胞计数与降钙素原对肿瘤患者合并细菌感染的诊断价值[J].现代肿瘤医学,2019,27(10):1786-1788. [20] 王宁, 刘利胜. 降钙素原与中性粒细胞和淋巴细胞计数比值对肿瘤患者细菌感染预测价值[J]. 中华肿瘤防治杂志, 2018, 25(8):595-598. [21] SONG J, PARK D W, MOON S, et al. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients:a prospective controlled study according to the Sepsis-3 definitions[J]. BMC Infect Dis, 2019, 19(1):968. [22] 卓慧, 范中红, 徐琛. 降钙素原指导ICU危重患者抗菌治疗的临床价值[J]. 世界最新医学信息文摘, 2019, 19(69):205-206. [23] SEN P, DEMIRDAL T, NEMLI S A, et al. Diagnostic and prognostic value of new bioscore in critically ill septic patients[J]. Arch Physiol Biochem, 2019, 2019(5):1-6. [24] 付守芝,曹松,叶先智,等.血液净化治疗对脓毒血症患者降钙素原、C反应蛋白及疗效的影响[J]. 中国实用内科杂志,2019,38(增刊2):80-82. [25] WINEBERG D, MOORE R, KRUGER D. Procalcitonin and bacterial sepsis in burn patients in south Africa[J]. J Surg Res, 2020, 246:490-498. [26] 陈淼, 林晓军, 张红璇, 等. ICU医院感染患者病原菌分布特点及血清PCT变化与预后临床价值分析[J]. 中华医院感染学杂志, 2017, 27(13):2951-2953, 2960. |